siRNA-mediated RUNX2 depletion impaired the positive transcriptional TGFβ effect on the expression of cadherin 6 (CDH6), whose product is a potential mesenchymal marker of the EMT program in thyroid cancer, controlling invasiveness of thyroid tumors [73]. The gene discussed is RUNX2; the disease is thyroid cancer.